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Abstract
Background: Current practices for renal replacement therapy (RRT) in ICU remain
poorly defined. The observational DOse REsponse Multicentre International collaborative
initiative (DO-RE-MI) survey addresses the issue of how the different modes of RRT are cur-
rently chosen and performed. The primary endpoint of DO-RE-MI will be the delivered dose
versus in ICU, 28-day, and hospital mortality, and the secondary endpoint, the hemodynamic
response to RRT. Here, we report the first preliminary descriptive analysis after 1-year
recruitment. Methods: Data from 431 patients in need of RRT with or without acute renal
failure (mean age 61.2  15.9) from 25 centers in 5 countries (Spain, Italy, Germany,
Portugal, France) were entered in electronic case report forms (CRFs) available via the web-
site acutevision.net. Results: On admission, 51% patients came from surgery, 36% from the
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